ClinicalTrials.gg
Not yet recruitingNCT05950230Updated Jul 18, 2023

Periodontal Health in Post COVID-19 Patients

An observational study in Post COVID-19 Condition, sponsored by Ain Shams University. Not yet recruiting. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-07-18.

Sponsored by Ain Shams University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2023, 3 years ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
90
Ages
25 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in COVID-19 by Ain Shams University — 1 open to participants now, 1 under way, none of them phase 3. COVID-19 · Ain Shams University.

Planned enrollment
11th of 20
90 · median 95
Started
2023
the only one that year
Observational
20 of 38
1 open now
Registered
37th of 38
by date

Among the 38 studies in COVID-19 by Ain Shams University, this one is the 11th largest by planned enrollment of the 20 observational ones that give a count, is the only one that started in 2023, is one of 20 observational ones, and was the 37th registered.

COVID-19

7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.

Browse COVID-19 studies →

Open to participants now

1 of the 38 studies in COVID-19 by Ain Shams University is open now.

Where they have run

Who these studies take

Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.

This study: 25 Years to 60 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in COVID-19 by Ain Shams University, or all of them as a file.
02

Study summary

The aim of this study is; To Assess the association between periodontal health and Matrix metalloproteinase-8 (MMP-8) level in Gingival Crevicular Fluid (GCF) in post COVID-19 patients.

Read the detailed description

Periodontitis is a serious problem disease due to its extensive prevalence. The most common definition of Periodontitis is a chronic inflammatory disease associated with many factors linked with plaque formation and characterized by the first clinical sign which is clinical attachment loss (CAL) and alveolar bone loss in a radiograph.

Initiation of periodontitis and progression depends on dysbiotic changes in the gingival sulcus microbiome in response to inflammation which activates of many molecular pathways, that result in loss of marginal periodontal ligament fibers, and apical migration of the junctional epithelium, which allows the bacterial biofilm to diffuse apically along the root surface.

Periodontitis is dependent on a number of origins but the main responsible is the dental plaque, While the progression is affected by the host response to local factors like plaque and calculus, genetics, environmental factors, systemic health, lifestyle habits, and various social determinants also play a role.

The etiology of periodontitis is the host periodontal tissues exposure to oral bacteria (including polymicrobial synergy, viruses, fungi, and parasites) that accumulate in oral biofilms, known as dental plaque, due to a lack of appropriate oral hygiene, which refers to a proper environment to retract inflammation products as polymorphonuclear, neutrophils, pro-inflammatory cytokines, matrix metalloproteinases, and reactive oxygen species, leading to gingivitis, when it is not treated well; a host immune system response is triggering progressing to periodontitis, in this case, other factors will act as progression more important than dental plaque, that means periodontitis is polymicrobial, multifactorial disease.

In a healthy periodontium, there is a microbial balance in the biofilm but when this balance is lost, increasing acid-producing concentrations and acid tolerating bacteria is a result in dental biofilm.

The process of this inflammatory imbalance activated by Porphyromonasgingivalis (Pg), Aggregatibacteractinomycetemcomitans (Aa), Tannerella forsythia(Tf), and Treponema denticola (Td) resulting from uncontrolled host immune response, this inflammatory process composed of 4 elements : (1)Bacteria, viruses, fungi, parasites, and cell damage, toxic cellular components, or any other harmful condition which is molecular patterns associated with pathogens(PAMP) and damage (DAMP); (2) cellular receptors that recognize these molecular patterns (PRR); (3) cytokines, chemokines which are proinflammatory mediators.; and (4) cells and tissues which proinflammatory mediators are targeting.

A set of inflammatory markers such as cytokines, like Tumour Necrosis Factor-α (TNF-α), Interleukin (IL)-1β, IL-4, IL-6 and IL-10, interleukin-17,serum C - Reactive Protein (CRP), prostaglandin E2 , Serum Ferritin,matrix metalloproteinases (MMPs), neutrophil collagenase, also known as matrix metalloproteinase-8 (MMP-8) and gelatinase B, also known as matrix metalloproteinase-9 (MMP-9)have high levels in periodontal disease, and specificallyelevatedactive Matrix metalloproteinase-8(MMP-8) in gingival tissue, saliva, and Gingival Crevicular Fluid (GCF) was the point of present for the early diagnosis of periodontitis.

The name of matrix metalloproteinases (MMPs) is derived from members of an enzyme family that are essential for preserving tissue allostasis and contribute to the normal turnover of periodontal tissues, they are also responsible for extracellular matrix proteins degradation during periodontitis. There are more than 20 members in the MMPs such as MMP-2, MMP-8, MMP-9, and MMP-13, Among them, MMP-8 is the most important collagenase in periodontitis; on top of that, MMP-8 is responsible for 90% to 95% of collagenolytic activity in gingival crevicular fluid. that is why MMP-8 is now considered one of the most promising diagnostic biomarkers for periodontitis in oral fluids, and proposed no or limited false positives comparing with traditionally used clinical examination as bleeding on probing.

Matrix metalloproteinase-8 (MMP-8; neutrophil collagenase or collagenase-2) secreted by neutrophils as a main proteolytic enzyme activated by inflammation mediators and can be used in diagnosing periodontitis and peri-implantitis.MMP-8 particularly damages two important structural components, interstitial collagens (types I-III), which is an extracellular matrix, also many pro-and anti-inflammatory cytokines, chemokines, and others that are non-matrix bioactive proteins degrade. several inflammatory cytokines, like IL-1β, TNF-α, can increase the expression of MMP-8 in inflammatory sites, in addition, T. denticola and P. gingivalis and their proteases lead to an increase in the activation of MMP-8.

Different chronic inflammatory diseases mainly periodontitis, peri-implantitis, diabetes, rheumatoid arthritis, increase MMP-8 level.

The MMP-8 test is mainly used for the assessment of periodontal health and the early detection of periodontitis and its staging, in addition to prediction of the risk of peri-implantitis and as monitoring tool during peri-implantitis treatment, while MMP-8levels might also be elevated with some inflammatory and malignant diseases like myocardial rupture, head and neck squamous cell carcinoma and breast cancer the MMP-8 test is not used as diagnostic tool for this condition as it's roll is still not fully understood.To detect MMP-8, we can use Enzyme-linked immunosorbent assay (ELISA), Time-resolved immunofluorometric assay (IFMA), MMP-8 specific chair-side dip-stick test and dentoAnalyzer device.

Gingival Crevicular Fluid (GCF) is generated from the postcapillary venules in the gingival plexus so that it brings the immune blood components to the sulcus as a function (like neutrophils, antibodies, and complement components), finding elevated secretion of GCF especially neutrophils which is an essential component in GCF reflecting inflammation state.

Collecting GCF from the gingival sulcus for analysis takes special attention in studying researches as it reflects periodontium and systemic health.In 2005 Loos and Tjoa reviewed eight periodontal inflammatory markers: alkaline phosphatase, cathepsin B, β-glucuronidase (βG), collagenase-2 (matrix metalloproteinase, MMP-8), gelatinase (MMP-9), dipeptidyl peptidase (DPP) II and III, aspartate aminotransferase (AST) and prostaglandin E2 (PGE2) and elastase enzyme .

Many studies revealed a High level of MMP-8 in GCF in chronic periodontitis patients as a diagnostic test, in association with increased activity of GCF collagenase, loss of connective tissue attachment, but after successful treatment MMP-8 level significantly decrease in GCF.

Different studies have indicated many human viruses particles in GCF : human immunodeficiency virus(HIV), herpes simplex virus (HSV), cytomegalovirus (CMV), Epstein-Barr virus(EBV), Zika virus, and currently Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) known as COVID-19, identification in GCF during nowadays pandemic, is a serious investigation of interest.

In 2020 Pfützner reported COVID-19 as a major pandemic causing severe acute respiratory syndrome. Most COVID-19 patients suffer from mild symptoms like fever, cough, dyspnea, and other respiratory complications, but it may progress to the severity condition like pneumonia or it can reach mortality in presence of aging or comorbidities as chronic lung disease, moderate to severe asthma, severe obesity, diabetes, chronic kidney disease, and liver disease, despite that many patients without comorbidities suffering from a complication of severCOVID-19 infection.

Recently, a lot of researchers gave evidence that there is a direct association between periodontal health and COVID-19 by approving that the oral cavity is a potential reservoir for the COVID-19 virus, mainly in GCF, Sub-gingival plaque biofilm, dental calculus, and saliva.

Viral particles of COVID-19 and its receptors were detected in oral fluids as Angiotensin Converting Enzyme II (ACE2), cluster of differentiation 147(CD147), and trans-membrane serine protease 2 (TMPRSS2) assist SARS-COV-2 entry to host cells, also TMPRSS and furin contribute to spreading the infection by cleaving the virus S protein of COVID-19 virus.

Assessment of periodontal health in patients helps in determining risk factors during and after the pandemic along with encouraging the need to maintain oral and periodontal health, as we as dental practitioners to be aware of the way of transmission even during non-surgical periodontal therapy.

In2021Pradeep et al.,proved that periodontitis severity is higher in COVID-19 patients than noninfected, they examined periodontal health by recording plaque index, calculus amount, tooth mobility, gingival bleeding, probing depth, recession and clinical attachment level, they indicated that all people should maintain their oral hygiene as one of the prevention methods of COVID-19 infection.

In a clinical study aiming to link between Periodontitis and COVID-19 MMP-8 levels in saliva and GCF was high in patients with periodontal disease and COVID-19, and interestingly some periodontal healthy patients showed an elevation of MMP-8 levels during their infection with COVID-19, which the authors related to the cytokine storm associated with COVID-19.

Because of association between MMP-8 and the tissue destruction in periodontitis/peri-implantitis diseases, it is known that this enzyme is abnormally elevated in COVID-19 patients in a response to cytokine storm related to COVID-19 infection(Sorsa et al., 2021).

As recommended by Ismoet al.,2020, in response to the relation between periodontitis and COVID-19 infections, MMP-8 test could possibly also help estimate the risk of periodontium damage and complications.

In our point of view this increase in MMP-8 levels could be associated with some long term complications of periodontal health after recovering from COVID-19 even for the periodontal healthy patients.

No assessment study has been carried out on the Egyptian population to evaluate periodontal health in post-COVID-19 patients, and none of the published literature worldwide correlated periodontal status and MMP-8 level in GCF for post-COVID-19 patients compared with none previously infected patients.

Thus, the present study was be carried out to assess the periodontal status in post-COVID-19 patients and examine MMP-8level in their GCF to investigate the links between post COVID-19 infection periodontal health and MMP-8 level.

03

Conditions studied

  • Post COVID-19 Condition

Browse trials for

Keywords

  • Periodontal health
  • Gingival Crevicular Fluid (GCF)
  • Matrix metalloproteinase-8 (MMP-8)
04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Case Group (Post-SARS-CoV-19) willinclude (n = 45) patients met the previous criteriaand had undergone (rRT-PCR) for the diagnosis of COVID-19 and recovered from all symptoms and finished isolation period or had negative rRT-PCR after infection(Yong, 2021, Marvisi et al., 2020, Liao et al., 2021, guidelines, 2021).

Control Group (Non-SARS-CoV-19) willinclude (n = 45) patients met the previous criteria with no records of COVID-19 infection or suspicious symptoms.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Both genders aged from 25-60.
  2. Systemically free(According to Cornell Medical Index-Health Questionnaire)(Pendleton et al., 2004).
  3. Having at least 20 teeth excluding third molars.
  4. Performing regular oral hygiene instructions.
  5. Patients with a current laboratory-confirmed SARS-CoV-2 infection after recovery time form Coronavirus who isolated themself at home (according to the Centers for Disease Control and Prevention (CDC) guidelines) until all of these things are true:(Jeong et al., 2021).

    1. Haven't had a fever for 24 hours without using a fever-reducing medicine.
    2. Symptoms are better, though they might not be totally gone.
    3. It's been at least 10 days since their symptoms started.
    4. Note that these recommendations do not apply to people with severe COVID-19 or with weakened immune systems ().
  6. For people who are asymptomatic (never develop symptoms): Isolation and precautions can be discontinued 10 days after the first positive viral test(Jeong et al., 2021).

Exclusion criteria

Exclusion Criteria:

  1. Smoking and Smokeless tobacco use.
  2. Patients suffering from post-covid permanent complications (lung fibrosis- Mucormycosis, ......) in cases group.
  3. Patients having gingivitis.
  4. Status of pregnancy, lactation.
  5. Obese patients.
  6. Patients who have undergone any periodontal therapy in the last 6 months.
  7. Vulnerable groups of patients' e.g. (prisoners, handicapped patients and orphans).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
90 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Cases

    45 Patients with history and results of recovered COVID-19 infection.

    Diagnostic Test: Assess Periodontal Health Status · Other: Collecte GCF samples by paperstrip

  • Control

    45 Patients with negative history of COVID-19 infection.

    Diagnostic Test: Assess Periodontal Health Status · Other: Collecte GCF samples by paperstrip

Interventions

  • Diagnostic testAssess Periodontal Health Status

    For all patients who are suitable for the study, the following clinical evaluation parameters will be recorded: * Plaque index (PI)(Silness and Löe, 1964). * Sulcus bleeding index(BOP)(Perez et al., 2008). * Probing depth (PD) (Polson et al., 1980). * Clinical attachment level (CAL) (Glavind and Löe, 1967). * Standardized Periapical Radiograph.

  • OtherCollecte GCF samples by paperstrip

    GCF samples will be collected from all participating individuals to assess the levels of MMP-8 from the deepest periodontal pocket in the area. The sample areas will be insulated with cotton rolls, saliva contamination will be prevented, all supragingival plaque will be eliminated. The paper strips will placed into the periodontal pocket until resistance is felt and then permitted to remain for 30s(Offenbacher et al., 1984, Megson et al., 2010).

06

What researchers measure

Primary outcomes

  1. Clinical Assessment

    Complete periodontal examination including the dentition status, numbers of present teeth, carious teeth, and missing teeth which including absent or indicated for extraction because of periodontal disease, and wasting diseases, such as abrasion and were recorded, followed by the recording of plaque scores, tooth mobility, gingival bleeding, probing depth (PD), recession (REC), and clinical attachment level (CAL) at six sites per tooth in all the teeth apart from the third molars using a unc-15 periodontal probe.

    Time frame: Baseline

  2. Biochemical Assessment

    Each GCF sample will be evaluated forMMP-8 level using commercially available ELISA kits in accordance with the manufacturers' instructions.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Acharya AB, Thakur S, Muddapur MV, Kulkarni RD. Cytokine ratios in chronic periodontitis and type 2 diabetes mellitus. Diabetes Metab Syndr. 2017 Oct-Dec;11(4):277-278. doi: 10.1016/j.dsx.2016.12.007. Epub 2016 Dec 13. PubMed 27989515 ↗
  • Anand PS, Jadhav P, Kamath KP, Kumar SR, Vijayalaxmi S, Anil S. A case-control study on the association between periodontitis and coronavirus disease (COVID-19). J Periodontol. 2022 Apr;93(4):584-590. doi: 10.1002/JPER.21-0272. Epub 2021 Aug 24. PubMed 34347879 ↗
  • Bansal T, Pandey A, D D, Asthana AK. C-Reactive Protein (CRP) and its Association with Periodontal Disease: A Brief Review. J Clin Diagn Res. 2014 Jul;8(7):ZE21-4. doi: 10.7860/JCDR/2014/8355.4646. Epub 2014 Jul 20. PubMed 25177663 ↗
  • Berton F, Rupel K, Florian F, Biasotto M, Pallavicini A, Di Lenarda R. Dental calculus-a reservoir for detection of past SARS-CoV-2 infection. Clin Oral Investig. 2021 Aug;25(8):5113-5114. doi: 10.1007/s00784-021-04001-8. Epub 2021 May 26. No abstract available. PubMed 34037853 ↗
  • Campisi G, Bizzoca ME, Lo Muzio L. COVID-19 and periodontitis: reflecting on a possible association. Head Face Med. 2021 May 11;17(1):16. doi: 10.1186/s13005-021-00267-1. PubMed 33975613 ↗
  • Casillas Santana MA, Dipp Velazquez FA, Samano Valencia C, Martinez Zumaran A, Zavala Alonso NV, Martinez Rider R, Salas Orozco MF. Saliva: What Dental Practitioners Should Know about the Role of This Biofluid in the Transmission and Diagnostic of SARS-CoV-2. Medicina (Kaunas). 2021 Apr 6;57(4):349. doi: 10.3390/medicina57040349. PubMed 33917276 ↗
  • Chakraborty S, Tewari S, Sharma RK, Narula SC. Effect of non-surgical periodontal therapy on serum ferritin levels: an interventional study. J Periodontol. 2014 May;85(5):688-96. doi: 10.1902/jop.2013.130107. Epub 2013 Jul 4. PubMed 23826646 ↗
  • Czumbel LM, Kiss S, Farkas N, Mandel I, Hegyi A, Nagy A, Lohinai Z, Szakacs Z, Hegyi P, Steward MC, Varga G. Saliva as a Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis. Front Med (Lausanne). 2020 Aug 4;7:465. doi: 10.3389/fmed.2020.00465. eCollection 2020. PubMed 32903849 ↗
  • Fatemi K, Rezaee SA, Banihashem SA, Keyvanfar S, Eslami M. Importance of MMP-8 in Salivary and Gingival Crevicular Fluids of Periodontitis Patients. Iran J Immunol. 2020 Sep;17(3):236-243. doi: 10.22034/iji.2020.81170.1512. PubMed 32996900 ↗
  • Glavind L, Loe H. Errors in the clinical assessment of periodontal destruction. J Periodontal Res. 1967;2(3):180-4. doi: 10.1111/j.1600-0765.1967.tb01887.x. No abstract available. PubMed 4237475 ↗
  • Gomes SC, Fachin S, da Fonseca JG, Angst PDM, Lamers ML, da Silva ISB, Nunes LN. Dental biofilm of symptomatic COVID-19 patients harbours SARS-CoV-2. J Clin Periodontol. 2021 Jul;48(7):880-885. doi: 10.1111/jcpe.13471. Epub 2021 May 4. PubMed 33899251 ↗
  • Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontol 2000. 2003;31:32-42. doi: 10.1034/j.1600-0757.2003.03103.x. No abstract available. PubMed 12656994 ↗
  • Gupta S, Mohindra R, Chauhan PK, Singla V, Goyal K, Sahni V, Gaur R, Verma DK, Ghosh A, Soni RK, Suri V, Bhalla A, Singh MP. SARS-CoV-2 Detection in Gingival Crevicular Fluid. J Dent Res. 2021 Feb;100(2):187-193. doi: 10.1177/0022034520970536. Epub 2020 Nov 2. PubMed 33138663 ↗
  • Gupta S, Mohindra R, Singla M, Khera S, Sahni V, Kanta P, Soni RK, Kumar A, Gauba K, Goyal K, Singh MP, Ghosh A, Kajal K, Mahajan V, Bhalla A, Sorsa T, Raisanen I. The clinical association between Periodontitis and COVID-19. Clin Oral Investig. 2022 Feb;26(2):1361-1374. doi: 10.1007/s00784-021-04111-3. Epub 2021 Aug 27. PubMed 34448073 ↗
  • Hajishengallis G, Chavakis T, Lambris JD. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 2000. 2020 Oct;84(1):14-34. doi: 10.1111/prd.12331. PubMed 32844416 ↗
  • Hentenaar DFM, De Waal YCM, Vissink A, Van Winkelhoff AJ, Meijer HJA, Liefers SC, Kroese FGM, Raghoebar GM. Biomarker levels in peri-implant crevicular fluid of healthy implants, untreated and non-surgically treated implants with peri-implantitis. J Clin Periodontol. 2021 Apr;48(4):590-601. doi: 10.1111/jcpe.13423. Epub 2021 Feb 16. PubMed 33454996 ↗
  • Hernandez M, Baeza M, Raisanen IT, Contreras J, Tervahartiala T, Chaparro A, Sorsa T, Hernandez-Rios P. Active MMP-8 Quantitative Test as an Adjunctive Tool for Early Diagnosis of Periodontitis. Diagnostics (Basel). 2021 Aug 20;11(8):1503. doi: 10.3390/diagnostics11081503. PubMed 34441437 ↗
  • Jeong YD, Ejima K, Kim KS, Iwanami S, Bento AI, Fujita Y, Jung IH, Aihara K, Watashi K, Miyazaki T, Wakita T, Iwami S, Ajelli M. Revisiting the guidelines for ending isolation for COVID-19 patients. Elife. 2021 Jul 27;10:e69340. doi: 10.7554/eLife.69340. PubMed 34311842 ↗
  • Liao B, Liu Z, Tang L, Li L, Gan Q, Shi H, Jiao Q, Guan Y, Xie M, He X, Zhao H, Chen W, Liu Y, Li L, Wang Y, Cao Y, Shi Y, Li Y, Lei C. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021 Jan 1;18(1):29-41. doi: 10.7150/ijms.49728. eCollection 2021. PubMed 33390771 ↗
  • Loos BG, Tjoa S. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000. 2005;39:53-72. doi: 10.1111/j.1600-0757.2005.00129.x. No abstract available. PubMed 16135064 ↗
  • Marsh PD. Microbiology of dental plaque biofilms and their role in oral health and caries. Dent Clin North Am. 2010 Jul;54(3):441-54. doi: 10.1016/j.cden.2010.03.002. PubMed 20630188 ↗
  • Marvisi M, Ferrozzi F, Balzarini L, Mancini C, Ramponi S, Uccelli M. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution. Int J Infect Dis. 2020 Oct;99:485-488. doi: 10.1016/j.ijid.2020.08.054. Epub 2020 Aug 22. PubMed 32841688 ↗
  • Megson E, Fitzsimmons T, Dharmapatni K, Bartold PM. C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J Clin Periodontol. 2010 Sep;37(9):797-804. doi: 10.1111/j.1600-051X.2010.01603.x. Epub 2010 Jul 3. PubMed 20618548 ↗
  • Mehrotra N, Singh S. Periodontitis. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK541126/ PubMed 31082170 ↗
  • Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodontal Res. 1984 Jan;19(1):1-13. doi: 10.1111/j.1600-0765.1984.tb01190.x. No abstract available. PubMed 6232362 ↗
  • Ozturk VO, Emingil G, Umeizudike K, Tervahartiala T, Gieselmann DR, Maier K, Kose T, Sorsa T, Alassiri S. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases. Arch Oral Biol. 2021 Apr;124:104955. doi: 10.1016/j.archoralbio.2020.104955. Epub 2021 Jan 20. PubMed 33556789 ↗
  • Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, Kornman KS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R, Tonetti MS. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018 Jun;45 Suppl 20:S162-S170. doi: 10.1111/jcpe.12946. PubMed 29926490 ↗
  • Pendleton N, Clague JE, Horan MA, Rabbitt PM, Jones M, Coward R, Lowe C, McInnes L. Concordance of Cornell medical index self-reports to structured clinical assessment for the identification of physical health status. Arch Gerontol Geriatr. 2004 May-Jun;38(3):261-9. doi: 10.1016/j.archger.2003.10.005. PubMed 15066312 ↗
  • Perez JR, Smukler H, Nunn ME. Clinical dimensions of the supraosseous gingivae in healthy periodontium. J Periodontol. 2008 Dec;79(12):2267-72. doi: 10.1902/jop.2008.080101. PubMed 19053916 ↗
  • Pfutzner A, Lazzara M, Jantz J. Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy. J Diabetes Sci Technol. 2020 Jul;14(4):769-771. doi: 10.1177/1932296820930287. Epub 2020 Jun 7. No abstract available. PubMed 32506937 ↗
  • Polson AM, Caton JG, Yeaple RN, Zander HA. Histological determination of probe tip penetration into gingival sulcus of humans using an electronic pressure-sensitive probe. J Clin Periodontol. 1980 Dec;7(6):479-88. doi: 10.1111/j.1600-051x.1980.tb02154.x. PubMed 6938528 ↗
  • Raisanen IT, Umeizudike KA, Parnanen P, Heikkila P, Tervahartiala T, Nwhator SO, Grigoriadis A, Sakellari D, Sorsa T. Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era. Med Hypotheses. 2020 Nov;144:110276. doi: 10.1016/j.mehy.2020.110276. Epub 2020 Sep 16. PubMed 33254580 ↗
  • Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; the Northwell COVID-19 Research Consortium; Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775. Erratum In: JAMA. 2020 May 26;323(20):2098. doi: 10.1001/jama.2020.7681. PubMed 32320003 ↗
  • Scannapieco FA, Gershovich E. The prevention of periodontal disease-An overview. Periodontol 2000. 2020 Oct;84(1):9-13. doi: 10.1111/prd.12330. PubMed 32844421 ↗
  • Sena K, Furue K, Setoguchi F, Noguchi K. Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E2 in human gingival fibroblasts. Arch Oral Biol. 2021 Sep;129:105201. doi: 10.1016/j.archoralbio.2021.105201. Epub 2021 Jun 21. PubMed 34174588 ↗
  • Sorsa T, Hernandez M, Leppilahti J, Munjal S, Netuschil L, Mantyla P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis. 2010 Jan;16(1):39-45. doi: 10.1111/j.1601-0825.2009.01603.x. Epub 2009 Jul 8. PubMed 19627514 ↗
  • Sorsa T, Sahni V, Buduneli N, Gupta S, Raisanen IT, Golub LM, Lee HM, Patila T, Bostanci N, Meurman J, Parnanen P, Nwhator SO, Singla M, Gauba K. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic. Expert Rev Proteomics. 2021 Aug;18(8):707-717. doi: 10.1080/14789450.2021.1976151. Epub 2021 Sep 11. PubMed 34468272 ↗
  • Thakur B, Dubey P, Benitez J, Torres JP, Reddy S, Shokar N, Aung K, Mukherjee D, Dwivedi AK. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. 2021 Apr 20;11(1):8562. doi: 10.1038/s41598-021-88130-w. PubMed 33879826 ↗
  • Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22. PubMed 34024217 ↗
  • Zhang L, Li X, Yan H, Huang L. Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2018 Jan;97(3):e9642. doi: 10.1097/MD.0000000000009642. PubMed 29504999 ↗

Related links

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2023; primary completion for Nov 2023, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2023
First posted
Jul 18, 2023
StartEst.
Aug 1, 2023
Primary completionEst.
Nov 1, 2023
CompletionEst.
Dec 1, 2023
Last update
Jul 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05950230
Responsible party
RANDA NIDAL ALZOUBI (Master Dental Student, Ain Shams University) — Principal investigator
First posted
Jul 18, 2023
Start date
Aug 1, 2023 (estimated)
Primary completion
Nov 1, 2023 (estimated)
Completion
Dec 1, 2023 (estimated)
Last update
Jul 18, 2023

Study contacts

RANDA N. ALZOUBI, Master
Contact
RANDAALZOUBI@dent.asu.edu.eg
1554391506 ext. 0020
Yasmine A. Fouad, Lecturer
Contact
1005793929 ext. 0020
Ola M. Ezzatt, Assoc.Prof.
study director · Associate Professor at Faculty of Dentistry, Ain Shams University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion